Free Trial

Demant A/S Unsponsored ADR (OTCMKTS:WILYY) Short Interest Up 50.0% in August

Demant A/S logo with Medical background

Key Points

  • Demant A/S saw a significant increase in short interest, rising by 50.0% to a total of 600 shares as of August 31st, based on a short-interest ratio of 6.0 days.
  • The stock opened at $19.25 and has a twelve-month range between $15.03 and $21.93, along with robust liquidity ratios.
  • Analysts have an average rating of "Buy" for Demant A/S, with upgrades from several financial institutions including a shift from "hold" to "strong-buy" by Citigroup.
  • MarketBeat previews the top five stocks to own by October 1st.

Demant A/S Unsponsored ADR (OTCMKTS:WILYY - Get Free Report) was the recipient of a significant growth in short interest during the month of August. As of August 31st, there was short interest totaling 600 shares, a growth of 50.0% from the August 15th total of 400 shares. Currently, 0.0% of the shares of the company are short sold. Based on an average trading volume of 100 shares, the short-interest ratio is presently 6.0 days. Based on an average trading volume of 100 shares, the short-interest ratio is presently 6.0 days. Currently, 0.0% of the shares of the company are short sold.

Demant A/S Price Performance

OTCMKTS WILYY remained flat at $18.52 on Friday. Demant A/S has a twelve month low of $15.03 and a twelve month high of $21.93. The firm's fifty day moving average is $19.49 and its two-hundred day moving average is $19.00. The company has a debt-to-equity ratio of 1.29, a current ratio of 1.63 and a quick ratio of 1.22.

Analyst Ratings Changes

Several analysts recently issued reports on WILYY shares. Citigroup upgraded Demant A/S from a "hold" rating to a "strong-buy" rating in a research note on Thursday, June 5th. Barclays upgraded shares of Demant A/S from a "strong sell" rating to a "hold" rating in a research note on Friday, June 20th. Two equities research analysts have rated the stock with a Strong Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Buy".

View Our Latest Report on Demant A/S

Demant A/S Company Profile

(Get Free Report)

Demant A/S operates as a hearing healthcare and audio technology company in Europe, North America, the Asia Pacific, Asia, and internationally. It operates through two segments: Hearing Healthcare and Communications. The Hearing Healthcare segment is involved in the manufacturing, servicing, and sale of hearing aids, and diagnostic products and services.

Further Reading

Should You Invest $1,000 in Demant A/S Right Now?

Before you consider Demant A/S, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Demant A/S wasn't on the list.

While Demant A/S currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.